Selected research
Industry Research
Sodium Iodine (131I) Drugs Industry Research Report 2026
Market perspective
The global Sodium Iodine (131I) Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Sodium Iodine (131I) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Sodium Iodine (131I) Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Sodium Iodine (131I) Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Sodium Iodine (131I) Drugs include Hta Co., Ltd, Yantai Dongcheng Biochemicals Co.,Ltd., Chengdu Gaotong Isotope Co.,Ltd., Mallinckrodt, Jubilant Radiopharma, International Isotopes, BWXT Medical Ltd, Bracco and AnazaoHealth, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Sodium Iodine (131I) Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Sodium Iodine (131I) Drugs Market by Company
Hta Co., Ltd
Yantai Dongcheng Biochemicals Co.,Ltd.
Chengdu Gaotong Isotope Co.,Ltd.
Mallinckrodt
Jubilant Radiopharma
International Isotopes
BWXT Medical Ltd
Bracco
AnazaoHealth
Sodium Iodine (131I) Drugs Segment by Type
Sodium Iodine [131I] Capsules
Sodium iodine [131I] Oral Solution
Sodium Iodine (131I) Drugs Segment by Application
Diagnosis and Investigation
Thyroid Cancer
Hyperthyroidism
Sodium Iodine (131I) Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sodium Iodine (131I) Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sodium Iodine (131I) Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sodium Iodine (131I) Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Sodium Iodine (131I) Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Sodium Iodine (131I) Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Sodium Iodine (131I) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Sodium Iodine [131I] Capsules
- Sodium iodine [131I] Oral Solution
Applications
- Diagnosis and Investigation
- Thyroid Cancer
- Hyperthyroidism
Companies covered
- Hta Co., Ltd
- Yantai Dongcheng Biochemicals Co.,Ltd.
- Chengdu Gaotong Isotope Co.,Ltd.
- Mallinckrodt
- Jubilant Radiopharma
- International Isotopes
- BWXT Medical Ltd
- Bracco
- AnazaoHealth
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Sodium Iodine (131I) Drugs Market Size (2021-2032)
- 2.2.2 Global Sodium Iodine (131I) Drugs Sales (2021-2032)
- 2.2.3 Global Sodium Iodine (131I) Drugs Market Average Price (2021-2032)
- 2.3 Sodium Iodine (131I) Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Sodium Iodine [131I] Capsules
- 2.3.3 Sodium iodine [131I] Oral Solution
- 2.4 Sodium Iodine (131I) Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Diagnosis and Investigation
- 2.4.3 Thyroid Cancer
- 2.4.4 Hyperthyroidism
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Sodium Iodine (131I) Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Sodium Iodine (131I) Drugs Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Sodium Iodine (131I) Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Sodium Iodine (131I) Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Sodium Iodine (131I) Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Sodium Iodine (131I) Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Sodium Iodine (131I) Drugs, Product Type & Application
- 3.8 Global Manufacturers of Sodium Iodine (131I) Drugs, Established Date
- 3.9 Global Sodium Iodine (131I) Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Hta Co., Ltd
- 4.1.1 Hta Co., Ltd Company Information
- 4.1.2 Hta Co., Ltd Business Overview
- 4.1.3 Hta Co., Ltd Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Hta Co., Ltd Sodium Iodine (131I) Drugs Product Portfolio
- 4.1.5 Hta Co., Ltd Recent Developments
- 4.2 Yantai Dongcheng Biochemicals Co.,Ltd.
- 4.2.1 Yantai Dongcheng Biochemicals Co.,Ltd. Company Information
- 4.2.2 Yantai Dongcheng Biochemicals Co.,Ltd. Business Overview
- 4.2.3 Yantai Dongcheng Biochemicals Co.,Ltd. Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Yantai Dongcheng Biochemicals Co.,Ltd. Sodium Iodine (131I) Drugs Product Portfolio
- 4.2.5 Yantai Dongcheng Biochemicals Co.,Ltd. Recent Developments
- 4.3 Chengdu Gaotong Isotope Co.,Ltd.
- 4.3.1 Chengdu Gaotong Isotope Co.,Ltd. Company Information
- 4.3.2 Chengdu Gaotong Isotope Co.,Ltd. Business Overview
- 4.3.3 Chengdu Gaotong Isotope Co.,Ltd. Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Chengdu Gaotong Isotope Co.,Ltd. Sodium Iodine (131I) Drugs Product Portfolio
- 4.3.5 Chengdu Gaotong Isotope Co.,Ltd. Recent Developments
- 4.4 Mallinckrodt
- 4.4.1 Mallinckrodt Company Information
- 4.4.2 Mallinckrodt Business Overview
- 4.4.3 Mallinckrodt Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mallinckrodt Sodium Iodine (131I) Drugs Product Portfolio
- 4.4.5 Mallinckrodt Recent Developments
- 4.5 Jubilant Radiopharma
- 4.5.1 Jubilant Radiopharma Company Information
- 4.5.2 Jubilant Radiopharma Business Overview
- 4.5.3 Jubilant Radiopharma Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Jubilant Radiopharma Sodium Iodine (131I) Drugs Product Portfolio
- 4.5.5 Jubilant Radiopharma Recent Developments
- 4.6 International Isotopes
- 4.6.1 International Isotopes Company Information
- 4.6.2 International Isotopes Business Overview
- 4.6.3 International Isotopes Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 International Isotopes Sodium Iodine (131I) Drugs Product Portfolio
- 4.6.5 International Isotopes Recent Developments
- 4.7 BWXT Medical Ltd
- 4.7.1 BWXT Medical Ltd Company Information
- 4.7.2 BWXT Medical Ltd Business Overview
- 4.7.3 BWXT Medical Ltd Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 BWXT Medical Ltd Sodium Iodine (131I) Drugs Product Portfolio
- 4.7.5 BWXT Medical Ltd Recent Developments
- 4.8 Bracco
- 4.8.1 Bracco Company Information
- 4.8.2 Bracco Business Overview
- 4.8.3 Bracco Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Bracco Sodium Iodine (131I) Drugs Product Portfolio
- 4.8.5 Bracco Recent Developments
- 4.9 AnazaoHealth
- 4.9.1 AnazaoHealth Company Information
- 4.9.2 AnazaoHealth Business Overview
- 4.9.3 AnazaoHealth Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 AnazaoHealth Sodium Iodine (131I) Drugs Product Portfolio
- 4.9.5 AnazaoHealth Recent Developments
5 Global Sodium Iodine (131I) Drugs Market Scenario by Region
- 5.1 Global Sodium Iodine (131I) Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Sodium Iodine (131I) Drugs Sales by Region: 2021-2032
- 5.2.1 Global Sodium Iodine (131I) Drugs Sales by Region: 2021-2026
- 5.2.2 Global Sodium Iodine (131I) Drugs Sales by Region: 2027-2032
- 5.3 Global Sodium Iodine (131I) Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Sodium Iodine (131I) Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Sodium Iodine (131I) Drugs Revenue by Region: 2027-2032
- 5.4 North America Sodium Iodine (131I) Drugs Market Facts & Figures by Country
- 5.4.1 North America Sodium Iodine (131I) Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Sodium Iodine (131I) Drugs Sales by Country (2021-2032)
- 5.4.3 North America Sodium Iodine (131I) Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Sodium Iodine (131I) Drugs Market Facts & Figures by Country
- 5.5.1 Europe Sodium Iodine (131I) Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Sodium Iodine (131I) Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Sodium Iodine (131I) Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Sodium Iodine (131I) Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Sodium Iodine (131I) Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Sodium Iodine (131I) Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Sodium Iodine (131I) Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Sodium Iodine (131I) Drugs Market Facts & Figures by Country
- 5.7.1 South America Sodium Iodine (131I) Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Sodium Iodine (131I) Drugs Sales by Country (2021-2032)
- 5.7.3 South America Sodium Iodine (131I) Drugs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Sodium Iodine (131I) Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Sodium Iodine (131I) Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Sodium Iodine (131I) Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Sodium Iodine (131I) Drugs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Sodium Iodine (131I) Drugs Sales by Type (2021-2032)
- 6.1.1 Global Sodium Iodine (131I) Drugs Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Sodium Iodine (131I) Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Sodium Iodine (131I) Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Sodium Iodine (131I) Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Sodium Iodine (131I) Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Sodium Iodine (131I) Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Sodium Iodine (131I) Drugs Sales by Application (2021-2032)
- 7.1.1 Global Sodium Iodine (131I) Drugs Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Sodium Iodine (131I) Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Sodium Iodine (131I) Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Sodium Iodine (131I) Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Sodium Iodine (131I) Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Sodium Iodine (131I) Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Sodium Iodine (131I) Drugs Value Chain Analysis
- 8.1.1 Sodium Iodine (131I) Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Sodium Iodine (131I) Drugs Production Mode & Process
- 8.2 Sodium Iodine (131I) Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Sodium Iodine (131I) Drugs Distributors
- 8.2.3 Sodium Iodine (131I) Drugs Customers
9 Global Sodium Iodine (131I) Drugs Analyzing Market Dynamics
- 9.1 Sodium Iodine (131I) Drugs Industry Trends
- 9.2 Sodium Iodine (131I) Drugs Industry Drivers
- 9.3 Sodium Iodine (131I) Drugs Industry Opportunities and Challenges
- 9.4 Sodium Iodine (131I) Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst